ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 34.55% of CLRB shares are held by financial institutions. MENDOTA FINANCIAL GROUP, LLC is the top corporate investor, holding 5 shares valued at $4.00. A 0% stake in Cellectar Biosciences, Inc. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
Among the CLRB insiders holding of 2.84% of the stake in company, MARXE AUSTIN W & GREENHOUSE DAVID M, 10 percent owner, holds the largest shares of 1.14M. HERTZBERG RICHARD, , is the second largest CLRB insider with ownership of 280K shares. BERNS PAUL L, director, stands third with possession of 117.37K shares of that stake.